Prevalence of depressive symptoms in postmenopausal women with low bone mineral density and/or prevalent vertebral fracture: results from the Multiple Outcomes of Raloxifene Evaluation (MORE) study.
about
Depression, antidepressants, and bone health in older adults: a systematic reviewVertebral fractures and self-perceived health in elderly women and men in a population-based cross-sectional study: the Tromsø Study 2007-08Psychological state, quality of life, and body composition in postmenopausal women with osteoporosis in LithuaniaDelayed fracture healing and increased callus adiposity in a C57BL/6J murine model of obesity-associated type 2 diabetes mellitus.Serotonin-norepinephrine reuptake inhibitor therapy in late-life depression is associated with increased marker of bone resorption.Update in serotonin and bone.Optimal management of perimenopausal depressionPsychometric properties of the osteoporosis assessment questionnaire (OPAQ) 2.0: results from the multiple outcomes of raloxifene evaluation (MORE) study.Depression and osteoporosis: a research synthesis with meta-analysisImpaired angiogenesis during fracture healing in GPCR kinase 2 interacting protein-1 (GIT1) knock out miceFracture Incidence, Quality of Life, and Back Pain during 18-Months Treatment with Teriparatide in Greek Postmenopausal Women with Osteoporosis: Results from the European Forsteo Observational StudyEffects of selective serotonin reuptake inhibitors on bone health in adults: time for recommendations about screening, prevention and management?Depressive symptomatology and fracture risk in community-dwelling older men and women.Depression as a risk factor for osteoporosis.Risk of Vertebral Fracture in Patients Diagnosed with a Depressive Disorder: A Nationwide Population-Based Cohort Study.Depression following fracture in women: a study of age-matched cohortsThe Effect of Antidepressants on Mesenchymal Stem Cell Differentiation.
P2860
Q27010527-EBEC74AC-8261-4902-AF1D-6C14538F96C4Q33590070-D469265E-692D-4D0B-ABD5-F63BE0B0C1B0Q33720247-D16B3D0E-D5A7-4508-AE57-8CE6C98E98E6Q33727997-DE33D22C-AD13-44E3-82C6-6E18DE53E15BQ33789841-D194AEE9-DB9B-4A38-8F48-2796A20EBC75Q34113148-31F48AC0-85FA-4AE1-8E20-A10E09C14669Q34272115-DF235BBC-9EE2-4FCD-9A55-577175447099Q34582203-64066FAD-2361-4297-B400-AE4BE84EA70AQ35059720-6D16489E-C647-4DD6-B1B5-273E67215C11Q35106711-C5B3E5C2-4B9D-4F5F-954A-B2E262598B7DQ35222686-3003E882-C86B-4C86-9C2D-787C017BF070Q36146084-FD08B9AD-1F6C-4615-9DD1-9D04B12DEC6BQ37335248-254EB9DA-FE8D-4A78-AB92-BE531134C40DQ37393313-7CE9A9AE-5E15-4E6B-9FC9-CCD05222A0FFQ37597040-4D272A5E-6F96-4A6C-A1FF-9863B60B91DBQ37598030-DBA9E716-5C87-4602-83BB-A0DB9659D057Q55313740-80DF7D15-5C2F-4F78-BAE3-D0FFF9A9CA4F
P2860
Prevalence of depressive symptoms in postmenopausal women with low bone mineral density and/or prevalent vertebral fracture: results from the Multiple Outcomes of Raloxifene Evaluation (MORE) study.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年学术文章
@wuu
2007年学术文章
@zh
2007年学术文章
@zh-cn
2007年学术文章
@zh-hans
2007年学术文章
@zh-my
2007年学术文章
@zh-sg
2007年學術文章
@yue
2007年學術文章
@zh-hant
name
Prevalence of depressive sympt ...... ifene Evaluation (MORE) study.
@en
Prevalence of depressive sympt ...... comes of Raloxifene Evaluation
@nl
type
label
Prevalence of depressive sympt ...... ifene Evaluation (MORE) study.
@en
Prevalence of depressive sympt ...... comes of Raloxifene Evaluation
@nl
prefLabel
Prevalence of depressive sympt ...... ifene Evaluation (MORE) study.
@en
Prevalence of depressive sympt ...... comes of Raloxifene Evaluation
@nl
P2093
P1476
Prevalence of depressive sympt ...... xifene Evaluation (MORE) study
@en
P2093
Kathryn H Moses
Michael E Minshall
Stuart L Silverman
P304
P407
P577
2007-01-01T00:00:00Z